Neopenda, PBC — SEC Form D Filing

Neopenda, PBC filed an SEC Form D on May 7, 2026, reporting $35K raised in Healthcare Technology.

Form D filing details

Filing
SEC Form D
Filing date
May 7, 2026
Amount reported
$35K
Round stage
Seed
Industry
Healthcare Technology
Website
https://www.neopenda.com/

What the company does

Securities: Debt. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Many patients in resource-limited settings suffer due to the lack of reliable medical equipment, resulting in preventable deaths, especially in newborns.

Solution

Neopenda has developed neoGuard™, a wearable device that continuously monitors vital signs to help healthcare providers deliver timely care in resource-constrained environments.

Why now

The pressing need for dependable medical equipment in developing regions makes this an urgent time to improve healthcare solutions.

Verdict

Investors said yes because they recognized the acute need for reliable healthcare technology in underserved markets, not because there was a robust competitive differentiation. They were implicitly betting on the essential life-saving potential of neoGuard™ in preventing infant mortality. However, the limited upside arises from the unclear market positioning and lack of specified buyers, which diminishes the narrative’s scalability and long-term viability.

Source: SEC EDGAR Form D filing